Literature DB >> 6396780

A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.

A Howell, R D Rubens, H Bush, W D George, J M Howat, D Crowther, R A Sellwood, J L Hayward, R K Knight, R D Bulbrook.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6396780     DOI: 10.1007/978-3-642-82357-2_10

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


× No keyword cloud information.
  2 in total

1.  Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

Authors:  T Saarto; C Blomqvist; P Rissanen; A Auvinen; I Elomaa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Authors:  P Poikonen; T Saarto; J Lundin; H Joensuu; C Blomqvist
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.